Loading...
XNYSPBH
Market cap3.67bUSD
Jan 08, Last price  
74.38USD
1D
0.76%
1Q
8.73%
Jan 2017
42.76%
IPO
315.07%
Name

Prestige Consumer Healthcare Inc

Chart & Performance

D1W1MN
XNYS:PBH chart
P/E
17.55
P/S
3.27
EPS
4.24
Div Yield, %
0.00%
Shrs. gr., 5y
-0.74%
Rev. gr., 5y
2.89%
Revenues
1.13b
-0.21%
303,318,000296,668,000318,634,000326,603,000312,715,000302,023,000336,510,000441,085,000623,597,000601,881,000714,623,000806,247,000882,060,0001,041,179,000975,777,000963,010,000943,365,0001,086,812,0001,127,725,0001,125,357,000
Net income
209m
P
13,459,00026,277,00036,078,00033,919,000-186,776,00032,115,00029,220,00037,212,00065,505,00072,615,00078,260,00099,907,00069,395,000339,570,000-35,800,000142,281,000164,682,000205,381,000-82,306,000209,339,000
CFO
249m
+8.36%
51,042,00053,861,00071,899,00044,989,00066,679,00059,427,00086,670,00067,452,000137,605,000111,582,000156,255,000174,350,000147,772,000210,110,000189,284,000217,124,000235,607,000259,922,000229,716,000248,926,000
Dividend
Sep 27, 20180.475 USD/sh
Earnings
Feb 06, 2025

Profile

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
URL
https://www.prestigebrands.com/
IPO date
Feb 10, 2005
Employees
560
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
1,125,357
-0.21%
1,127,725
3.76%
1,086,812
15.21%
Cost of revenue
760,376
754,846
732,025
Unusual Expense (Income)
NOPBT
364,981
372,879
354,787
NOPBT Margin
32.43%
33.06%
32.64%
Operating Taxes
66,686
(11,609)
57,077
Tax Rate
18.27%
16.09%
NOPAT
298,295
384,488
297,710
Net income
209,339
-354.34%
(82,306)
-140.07%
205,381
24.71%
Dividends
Dividend yield
Proceeds from repurchase of equity
(25,000)
(50,000)
4,124
BB yield
0.69%
1.60%
-0.15%
Debt
Debt current
12,304
19,520
9,112
Long-term debt
1,147,356
1,378,634
1,526,948
Deferred revenue
Other long-term liabilities
412,781
8,165
7,484
Net debt
1,113,191
1,339,665
1,953,792
Cash flow
Cash from operating activities
248,926
229,716
259,922
CAPEX
(9,550)
(7,784)
(9,642)
Cash from investing activities
(20,111)
(11,584)
(256,511)
Cash from financing activities
(241,015)
(185,846)
(7,569)
FCF
274,802
322,551
294,016
Balance
Cash
46,469
58,489
27,185
Long term investments
(444,917)
Excess cash
2,103
Stockholders' equity
1,307,257
1,100,842
1,195,676
Invested Capital
3,213,673
2,829,997
3,088,779
ROIC
9.87%
12.99%
9.98%
ROCE
11.36%
11.61%
10.04%
EV
Common stock shares outstanding
50,178
49,889
50,842
Price
72.56
15.86%
62.63
18.30%
52.94
20.10%
Market cap
3,640,916
16.53%
3,124,548
16.09%
2,691,575
20.66%
EV
4,754,107
4,464,213
4,645,367
EBITDA
395,656
405,504
386,879
EV/EBITDA
12.02
11.01
12.01
Interest
67,160
69,164
64,287
Interest/NOPBT
18.40%
18.55%
18.12%